Van den Branden, C <br/><br/>
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.  [electronic resource] 

 -  Nephron  1997 
 - 319-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1660-8151 
<br/><br/><label>Standard No.: </label>10.1159/000190295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--pharmacology<br/>Aldehydes--metabolism<br/>Animals<br/>Antioxidants--metabolism<br/>Blood Pressure--drug effects<br/>Carbazoles--pharmacology<br/>Carvedilol<br/>Free Radical Scavengers--metabolism<br/>Glomerulosclerosis, Focal Segmental--drug therapy<br/>Hydrogen Peroxide--metabolism<br/>Kidney Cortex--enzymology<br/>Kidney Failure, Chronic--drug therapy<br/>Lipid Peroxidation--drug effects<br/>Male<br/>Malondialdehyde--metabolism<br/>Nephrectomy<br/>Propanolamines--pharmacology<br/>Propranolol--pharmacology<br/>Rats<br/>Rats, Wistar